Sharemaestro Newsreel

Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Insulet Corporation (NASDAQ:PODD) by 67.2% in the second quarter of 2026, selling 173,086 shares and retaining 84,633 shares valued at approximately $12.9 million. This reduction comes despite Insulet exceeding second-quarter expectations with strong EPS and …

PODD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Insulet Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and its officers for alleged violations of federal securities laws. The lawsuit claims that Insulet made materially false and misleading statements regarding defective manufacturing controls and procedures, creating …

Assenagon Asset Management S.A. Has $15.20 Million Stock Position in Glaukos Corporation $GKOS

Assenagon Asset Management S.A. significantly increased its stake in Glaukos Corporation (NYSE:GKOS) by 932.5% in the second quarter, now holding 108,736 shares valued at approximately $15.2 million. Glaukos reported strong Q2 earnings with a 49.6% revenue increase year-over-year and beat analyst EPS expectations, though …

Assenagon Asset Management S.A. Has $16.10 Million Stake in STERIS plc $STE

Assenagon Asset Management S.A. significantly increased its stake in STERIS plc by 56.5% during the second quarter, now holding 76,440 shares valued at $16.10 million. Institutional investors collectively own 94.69% of STERIS, which recently exceeded earnings expectations with $2.59 EPS and $1.49 billion in …

Agnelli family's Exor can raise Philips stake to 22% under updated agreement

Exor, the investment arm of Italy's Agnelli family and Philips' largest shareholder, has extended its agreement with the health technology firm, allowing it to increase its stake to up to 22%. This updated agreement follows Exor's initial 15.1% stake announced in August 2023, a …

Owlet Inc (OWLT) Earnings Date & Reports & Earnings News

Neuronetics (STIM) Earnings Date and Reports 2026 $STIM

5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call

5 Revealing Analyst Questions From Zimmer Biomet's Q2 Earnings Call Zimmer Biomet's second quarter results were driven by strong execution in its hip franchise, robust technology sales, and progress in the U.S. sales force transformation. CEO Ivan Tornos highlighted that new product adoption, such …

Senseonics Holdings Inc (SENS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates

CeriBell, Inc. (CBLL) reported a Q2 loss of $0.51 per share, missing the Zacks Consensus Estimate of a $0.45 loss, but exceeded revenue estimates with $28.1 million. Despite underperforming the S&P 500 this year, the company's revenue has topped consensus estimates four times in …

CeriBell Lifts 2026 Revenue Forecast on AI EEG Growth, Reports Wider Quarterly Loss

Ceribell has raised its 2026 revenue forecast to $114-$117 million after a 33% increase in Q2 sales, driven by new hospital accounts and higher utilization. Despite strong growth, the GAAP net loss widened by 41% to $19.3 million due to operating expenses rising faster …

ITOC, PTHL DEADLINE: Levi & Korsinsky Reminds iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) Investors of Upcoming Securities Class Action Deadline

Levi & Korsinsky, LLP reminds institutional investors of an upcoming securities class action deadline for iTonic Holdings Ltd (ITOC, PTHL) shareholders. The lawsuit, filed on behalf of investors who purchased securities between September 5, 2024, and July 29, 2025, alleges the company failed to …

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell, Inc. announced FDA 510(k) clearance for two new AI algorithm enhancements for its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These enhancements aim to improve the precision and efficiency of critical-care EEG review by filtering complex background interference and streamlining the …

Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Boston Scientific Corporation (NYSE:BSX) has an average "Moderate Buy" rating from thirty-one brokerages, with an average 12-month price target of $71.62. The company recently exceeded quarterly earnings expectations with adjusted EPS of $0.86 and revenue of $5.44 billion, and announced a $5 billion share …

Exor and Philips Extend Long-term Relationship Agreement

Royal Philips Clinician and patient with Azurion and IntraSightClinician and patient with Azurion and IntraSight Exor logoExor logo Disney themes incorporated into Philips Ambient Experience for MRIDisney themes incorporated into Philips Ambient Experience for MRI Nurses at central monitoring stationNurses at central monitoring station …

Should iRhythm’s Stronger Q2 2026 Results and Higher Guidance Amid Class Action Settlement Require Action From iRhythm Holdings (IRTC) Investors?

Oil prices hold steady after jumping 5%, while Asian shares are mixed

BANGKOK (AP) — Shares were mixed in Asia, while oil prices were holding steady Tuesday after jumping the day before as uncertainty persisted over when the Strait of Hormuz could reopen and get the global flow of crude going again. U.S. futures edged higher. …

Quanterix Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:QTRX) 2026-08-11

CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...

CeriBell Inc (CBLL) reported a significant revenue increase of 33% year-over-year to $28.1 million in Q2 2026, driven by strong product and subscription growth. Despite widening net losses due to increased operating expenses and IP litigation costs, the company achieved a record gross margin …

Smith & Nephew SNATS, Inc. (SNN) Stock Forecasts

Varex Imaging Agrees to Teledyne All-Cash Acquisition

Varex Imaging has agreed to be acquired by Teledyne Technologies in an all-cash deal valued at approximately $1.1 billion. The acquisition, pending shareholder and regulatory approvals, will result in Varex becoming a wholly-owned subsidiary of Teledyne and its delisting from Nasdaq in early 2027. …

Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)

Wolf Haldenstein Adler Freeman & Herz LLP reminds investors of Nano-X Imaging Ltd. (NASDAQ: NNOX) of a class action lawsuit with a lead plaintiff deadline of today, August 11, 2026. The lawsuit alleges that Nano-X overstated its operational efficiency and product demand, leading to …

5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call

Inspire Medical Systems (INSP) surpassed Q2 analyst expectations with improved operating income and positive cash flow, driven by better coding clarity and cost discipline. Management raised its full-year revenue and Adjusted EPS guidance, demonstrating resilience despite a year-on-year revenue decline. Analyst questions focused on …

Apyx Medical Corp (BOV.MU) Analyst insights, Price targets and Recommendations

This article provides an overview of analyst insights, price targets, and recommendations for Apyx Medical Corp (BOV.MU), traded on the Munich exchange. It details recent upgrades and downgrades from various financial firms, including BTIG, Roth Capital, and HC Wainwright & Co., with their respective …

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Inogen Launches First CPAP Mask Portfolio

Inogen Inc. has launched its Aurora CPAP mask portfolio in the United States, marking its entry into the obstructive sleep apnea market. This expansion aims to leverage existing distribution channels to offer a variety of mask designs—F1 Full Face, N1 Nasal Cushion, and P1 …

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

NovoCure (NVCR) is experiencing renewed optimism due to its tumor treating fields devices and hopes for upcoming FDA approval, leading to a recent surge in its stock price. Despite significant short-term gains, the stock has seen declines over three and five years. Analysts consider …

Inogen Launches Voxi 5 Stationary Oxygen Concentrator

Inogen Inc. has launched the Voxi 5, a new stationary oxygen concentrator (SOC) developed with Yuwell Medical, to expand access to oxygen therapy for long-term care patients in the US. This device provides 1-5 liters per minute of continuous flow oxygen, offering a compact …

Why PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses

PROCEPT BioRobotics (PRCT) saw its stock rise 9.6% despite reporting wider net losses in Q2 2026, driven by reaffirming its full-year 2026 revenue guidance of US$390 million to US$410 million. The company's investment narrative centers on Aquablation adoption and the path to sustainable profitability, …

Artivion (AORT) Revenue Rose As Losses Emerged, Is It Still 37% Below Fair Value?

Artivion (AORT) recently reported Q2 2026 results showing increased revenue but a shift to losses. Despite a year-to-date share price decline, the company's valuation narrative suggests it is 37.4% undervalued, with a fair value of $42. This undervaluation hinges on continued regulatory approvals, new …

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day

Zimmer Biomet Holdings Inc. (ZBH) saw its stock advance by 1.27% to $97.78 on Monday, outperforming the broader market which experienced a dismal trading session. This rise broke a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial …

Tactile Medical projects $360M-$366M 2026 revenue as airway clearance ordering normalizes in Q4

Earnings Call Insights: Tactile Systems Technology (TCMD) Q2 2026 MANAGEMENT VIEW * "We delivered another strong quarter of execution in Q2, highlighted by continued strength in our lymphedema business and meaningful profitability expansion." (CEO, President & Director Sheri Dodd) * "Based on our first …

Adapthealth director Dale Wolf buys $244,600 in company stock

Dale B. Wolf, a director at AdaptHealth Corp. (NASDAQ:AHCO), recently purchased 40,000 shares of company stock for $244,600 in early August 2026, with prices between $5.83 and $6.37 per share. These insider purchases occurred while AHCO shares traded near their 52-week low, and InvestingPro …

Is Globus Medical (GMED) Cheap After Its Earnings Beat And Higher EPS Outlook?

Globus Medical (GMED) has seen positive momentum with a 7.39% 90-day share price return following an earnings beat and higher EPS outlook. Despite a year-to-date dip, its 1-year total shareholder return is 40.41%. A valuation narrative suggests the stock is 23.3% undervalued, with a …

CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Cuts Target Price to $13

CCORF has reiterated its Buy rating for Orthofix Medical (OFIX.US) but has lowered its target price to $13. This indicates a continued positive outlook on the company despite a revised valuation.